These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 7145012)

  • 1. [Comparative evaluation of the therapeutic effectiveness of drugs of different mechanisms of action in cerebral atherosclerosis].
    Sobczyk W
    Neurol Neurochir Pol; 1982; 16(4):245-60. PubMed ID: 7145012
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Comparison of the effectiveness of anginin and stugeron treatment of cerebral arteriosclerosis].
    Sobczyk W; Kruszewska J; Szymchel J
    Neurol Neurochir Pol; 1980; 14(2):183-9. PubMed ID: 6993976
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Piracetam and the indicators of cerebral hemodynamics, lipid metabolism and rheological properties of blood in the initial forms of cerebrovascular disorders].
    Eninia GI; Timofeeva TN
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1990; 90(11):20-3. PubMed ID: 1963971
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Omaron in the restorative treatment of patients with chronic cerebrovascular insufficiency].
    Stroganova IM; Kiparisov MA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2010; 110(1):70-2. PubMed ID: 20443242
    [No Abstract]   [Full Text] [Related]  

  • 5. [Effect of piracetam on cerebral hemodynamics in patients with arteriosclerosis and dyscirculatory encephalopathy].
    Vesel'skiĭ ISh; Voroniuk MI
    Klin Med (Mosk); 1986 Jun; 64(6):41-4. PubMed ID: 3747435
    [No Abstract]   [Full Text] [Related]  

  • 6. [Current treatment of cerebrovascular disorder with vasoactive drugs].
    Lebiediewa NW
    Neurol Neurochir Pol; 1981; 15(4):417-21. PubMed ID: 6895779
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of hypercapnia on the cerebrovascular activities of some drugs used in the treatment of cerebral ischemia.
    Cosnier D; Cheucle M; Rispat G; Streichenberger G
    Arzneimittelforschung; 1977; 27(8):1566-9. PubMed ID: 578747
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The effect of pyritinol on the human cerebrovascular circulation (author's transl)].
    Herrschaft H
    MMW Munch Med Wochenschr; 1978 Sep; 120(39):1263-8. PubMed ID: 100689
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The efficacy of the cerebral metabolic enhancers in the treatment of senile dementia.
    Branconnier RJ
    Psychopharmacol Bull; 1983; 19(2):212-9. PubMed ID: 6408682
    [No Abstract]   [Full Text] [Related]  

  • 10. [Tinnitus and lipid metabolism disorders. Value of early normolipemic treatment].
    Albertini F
    Sem Hop Ther; 1977 Apr; 53(4):261-3. PubMed ID: 882873
    [No Abstract]   [Full Text] [Related]  

  • 11. [Effect of aminalon electrophoresis on brain bioelectrical activity in cerebral atherosclerosis patients with disordered cerebral blood circulation].
    Danilova IN; Neretin VIa; Nesterova LA
    Vopr Kurortol Fizioter Lech Fiz Kult; 1980; (4):13-7. PubMed ID: 7415011
    [No Abstract]   [Full Text] [Related]  

  • 12. [Sturgeron treatment effectiveness in early cerebral arteriosclerosis].
    Belonog RP; Karaban' IN
    Vrach Delo; 1980 Sep; (9):67-9. PubMed ID: 7423956
    [No Abstract]   [Full Text] [Related]  

  • 13. [Effect of Cinnarizine in cerebral arteriosclerosis. Improvement of the clinical picture as a result of increased oxygen supply and utilization due to Cinnarizine].
    Reimann-Hunziker R; Reimann-Hunziker GJ
    Praxis; 1969 Sep; 58(39):1239-42. PubMed ID: 4899503
    [No Abstract]   [Full Text] [Related]  

  • 14. Vasodilators in senile dementias: a review of the literature.
    Yesavage JA; Tinklenberg JR; Hollister LE; Berger PA
    Arch Gen Psychiatry; 1979 Feb; 36(2):220-3. PubMed ID: 420543
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A comparative evaluation of the effect of vasodilator drugs on the cerebral vessels of patients with cerebral atherosclerosis (rheoencephalographic studies)].
    Eninie GI; Smeltere ES
    Klin Med (Mosk); 1972 Sep; 50(9):39-44. PubMed ID: 4652968
    [No Abstract]   [Full Text] [Related]  

  • 16. [Can disorders of cerebral performance be improved by drugs? Use of vaso- and metabolically active substances in primary degenerative brain diseases and cerebral arteriosclerosis].
    Herrschaft H
    Fortschr Med; 1987 Nov; 105(32):637-40. PubMed ID: 3323002
    [No Abstract]   [Full Text] [Related]  

  • 17. [Naftidrofuryl in cerebrovascular sclerosis. Ophthalmodynamic findings in acute and long term experiment].
    Finke J; Kettlitz UP
    ZFA (Stuttgart); 1976 Sep; 52(27):1400-3. PubMed ID: 790807
    [No Abstract]   [Full Text] [Related]  

  • 18. [Cinnarizine and phosphatidyl choline in the treatment of cerebral arteriosclerotic pathology and arteriosclerosis of the lower extremities. Comparative study].
    Ciammaichella A; Solitro A; Arcuri P
    Minerva Cardioangiol; 1975 Mar; 23(3):191-200. PubMed ID: 1128771
    [No Abstract]   [Full Text] [Related]  

  • 19. [Phezam efficacy in patients with chronic cerebral ischemic disease].
    Boĭko AN; Kabanov AA; Es'kina TA; Sheliakina LA; Shchukin AI; Batysheva TT; Artemova IIu; Vdovichenko TV; Volovets SA; Ganzhula PA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2005; 105(1):36-41. PubMed ID: 15704481
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Brain metabolism studies under the treatment with pyrithioxin].
    Becker K; Hoyer S
    Dtsch Z Nervenheilkd; 1966 Mar; 188(3):200-9. PubMed ID: 5983388
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.